Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Long-Term Investments (2020 - 2021)

Historic Long-Term Investments for Insight Molecular Diagnostics (IMDX) over the last 2 years, with Q1 2021 value amounting to $2.0 million.

  • Insight Molecular Diagnostics' Long-Term Investments fell 8086.51% to $2.0 million in Q1 2021 from the same period last year, while for Mar 2021 it was $2.0 million, marking a year-over-year decrease of 8086.51%. This contributed to the annual value of $13.4 million for FY2020, which is N/A changed from last year.
  • According to the latest figures from Q1 2021, Insight Molecular Diagnostics' Long-Term Investments is $2.0 million, which was down 8086.51% from $13.4 million recorded in Q4 2020.
  • Insight Molecular Diagnostics' 5-year Long-Term Investments high stood at $14.3 million for Q2 2020, and its period low was $2.0 million during Q1 2021.